Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
Biochem Biophys Res Commun
    October 2023
  1. FRASER-PITT D, Mercer DK, Francis ML, Toledo-Aparicio D, et al
    Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection.
    Biochem Biophys Res Commun. 2023;677:168-181.
    >> Share

  2. YAO Y, Zhang Y, Li Z, Chen Z, et al
    A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
    Biochem Biophys Res Commun. 2023;675:113-121.
    >> Share

    September 2023
  3. FUJISAWA M, Adachi Y, Onodera T, Shiwa-Sudo N, et al
    High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection.
    Biochem Biophys Res Commun. 2023;673:114-120.
    >> Share

    August 2023
  4. SUN W, Zhang Z, Chen M, Liu X, et al
    Discovery of a potent inhibitor targeting the cap-binding domain of the PB2 subunit of influenza RNA-dependent RNA polymerase.
    Biochem Biophys Res Commun. 2023;678:97-101.
    >> Share

  5. YU J, Im H, Lee G
    Unwinding mechanism of SARS-CoV helicase (nsp13) in the presence of Ca(2+), elucidated by biochemical and single-molecular studies.
    Biochem Biophys Res Commun. 2023;668:35-41.
    >> Share

    July 2023
  6. BEAUDOIN CA, Petsolari E, Hamaia SW, Hala S, et al
    SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.
    Biochem Biophys Res Commun. 2023;666:61-67.
    >> Share

    June 2023
  7. ISHII H, Jounai K, Tsuji R, Ohshio K, et al
    Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication.
    Biochem Biophys Res Commun. 2023;662:26-30.
    >> Share

  8. CHU X, Ding X, Yang Y, Lu Y, et al
    Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2.
    Biochem Biophys Res Commun. 2023;660:43-49.
    >> Share

    May 2023
  9. ITO K, Goto K, Shirakawa R, Horiuchi H, et al
    Platelet alphaIIbbeta3 integrin binds to SARS-CoV-2 spike protein of alpha strain but not wild type and omicron strains.
    Biochem Biophys Res Commun. 2023;657:80-85.
    >> Share

  10. ZHOU Y, Wang W, Zeng P, Feng J, et al
    Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814 and PF-07321332.
    Biochem Biophys Res Commun. 2023;657:16-23.
    >> Share

    February 2023
  11. AHN MJ, Kang JA, Hong SM, Lee KS, et al
    Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera.
    Biochem Biophys Res Commun. 2023;646:8-18.
    >> Share

  12. KAWASHIMA S, Matsui Y, Adachi T, Morikawa Y, et al
    Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally.
    Biochem Biophys Res Commun. 2023;645:132-136.
    >> Share

  13. HOSSAIN MI, Myers M, Herath D, Aldhumani AH, et al
    4-Aminoquinolines modulate RNA structure and function: Pharmacophore implications of a conformationally restricted polyamine.
    Biochem Biophys Res Commun. 2023;644:55-61.
    >> Share

    January 2023
  14. CHARLES J, McCann N, Ploplis VA, Castellino FJ, et al
    Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein.
    Biochem Biophys Res Commun. 2023;641:61-66.
    >> Share

    November 2022
  15. MUHAMMAD JS, ElGhazali G, Shafarin J, Mohammad MG, et al
    SARS-CoV-2-induced hypomethylation of the ferritin heavy chain (FTH1) gene underlies serum hyperferritinemia in severe COVID-19 patients.
    Biochem Biophys Res Commun. 2022;631:138-145.
    >> Share

  16. PADHI AK, Tripathi T
    Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes.
    Biochem Biophys Res Commun. 2022;629:54-60.
    >> Share

    October 2022
  17. CHAKRABORTY S, Saha A, Saha C, Ghosh S, et al
    Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants.
    Biochem Biophys Res Commun. 2022;627:168-175.
    >> Share

  18. ZHAO H, Liu J, He L, Zhang L, et al
    Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
    Biochem Biophys Res Commun. 2022;626:114-120.
    >> Share

  19. CHOI JY, Park JH, Jo C, Kim KC, et al
    SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells.
    Biochem Biophys Res Commun. 2022;626:66-71.
    >> Share

  20. OKI N, Yamada S, Tanaka T, Fukui H, et al
    Curcumin partly prevents ISG15 activation via ubiquitin-activating enzyme E1-like protein and decreases ISGylation.
    Biochem Biophys Res Commun. 2022;625:94-101.
    >> Share

  21. POURFARJAM Y, Ma Z, Kim IK
    ATP enhances the error-prone ribonucleotide incorporation by the SARS-CoV-2 RNA polymerase.
    Biochem Biophys Res Commun. 2022;625:53-59.
    >> Share

    September 2022
  22. LYKHMUS O, Kalashnyk O, Koval L, Krynina O, et al
    Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice.
    Biochem Biophys Res Commun. 2022;622:57-63.
    >> Share

  23. MISHRA PM, Anjum F, Uversky VN, Nandi CK, et al
    SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors.
    Biochem Biophys Res Commun. 2022;620:8-14.
    >> Share

    August 2022
  24. LI H, Ren H, Cao L, Guo J, et al
    Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice.
    Biochem Biophys Res Commun. 2022;618:54-60.
    >> Share

  25. WEI W, Kong N, Liu MZ, Han T, et al
    Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease.
    Biochem Biophys Res Commun. 2022;616:8-13.
    >> Share

  26. ZHANG B, Li Y, Feng Q, Song L, et al
    Structural insights into ORF10 recognition by ZYG11B.
    Biochem Biophys Res Commun. 2022;616:14-18.
    >> Share

    July 2022
  27. SUGAMOTO K, Tanaka YL, Saito A, Goto Y, et al
    Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes.
    Biochem Biophys Res Commun. 2022;615:56-62.
    >> Share

  28. MINAGAWA H, Sawa H, Fujita T, Kato S, et al
    A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant).
    Biochem Biophys Res Commun. 2022;614:207-212.
    >> Share

  29. DUAN L, Yin H, Liu J, Wang W, et al
    Fetal neurodevelopmental spatio-temporal dynamic transcriptional landscape of maternal insult-induce autism spectrum disorder risk.
    Biochem Biophys Res Commun. 2022;614:183-190.
    >> Share

    June 2022
  30. BEHERA J, Ison J, Voor MJ, Tyagi SC, et al
    Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss.
    Biochem Biophys Res Commun. 2022;620:180-187.
    >> Share

    May 2022
  31. MIYOSHI H, Ichinohe R, Koshikawa T
    High-resolution melting analysis after nested PCR for the detection of SARS-CoV-2 spike protein G339D and D796Y variations.
    Biochem Biophys Res Commun. 2022;606:128-134.
    >> Share

  32. WANG L, Zhao L, Li Y, Ma P, et al
    Harnessing coronavirus spike proteins' binding affinity to ACE2 receptor through a novel baculovirus surface display system.
    Biochem Biophys Res Commun. 2022;606:23-28.
    >> Share

  33. LIU P, Zhang Y, Li Z, Huang J, et al
    Structural insights revealed by crystal structure of B38-CAP, an isoenzyme of carboxypeptidase ACE2, the receptor of SARS-CoV-2.
    Biochem Biophys Res Commun. 2022;606:17-22.
    >> Share

  34. GHAZANFARI D, Courreges MC, Belinski L, Bergmeier SC, et al
    Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19.
    Biochem Biophys Res Commun. 2022;605:171-176.
    >> Share

  35. WU Q, Yan S, Wang Y, Li M, et al
    Discovery of 4'-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor.
    Biochem Biophys Res Commun. 2022;604:76-82.
    >> Share

    April 2022
  36. YUE K, Yao B, Shi Y, Yang Y, et al
    The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
    Biochem Biophys Res Commun. 2022;601:129-136.
    >> Share

    February 2022
  37. HEALY EF
    How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17.
    Biochem Biophys Res Commun. 2022;593:52-56.
    >> Share

  38. KOLEY T, Kumar M, Goswami A, Ethayathulla AS, et al
    Structural modeling of Omicron spike protein and its complex with human ACE-2 receptor: Molecular basis for high transmissibility of the virus.
    Biochem Biophys Res Commun. 2022;592:51-53.
    >> Share

  39. RATH SL, Padhi AK, Mandal N
    Scanning the RBD-ACE2 molecular interactions in Omicron variant.
    Biochem Biophys Res Commun. 2022;592:18-23.
    >> Share

  40. LEE JW, Kim MN, Kim EG, Leem JS, et al
    Chitinase 3-like 1 is involved in the induction of IL-8 expression by double-stranded RNA in airway epithelial cells.
    Biochem Biophys Res Commun. 2022;592:106-112.
    >> Share

  41. CHEN J, Zhang Y, Zeng D, Zhang B, et al
    Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2.
    Biochem Biophys Res Commun. 2022;591:118-123.
    >> Share

  42. MAO XD, Li T, Xu Z, Liu K, et al
    Pathogenesis of COVID-19 and the quality control of nucleic acid detection.
    Biochem Biophys Res Commun. 2022;591:137-142.
    >> Share

  43. CHIOU WC, Chen JC, Chen YT, Yang JM, et al
    The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
    Biochem Biophys Res Commun. 2022;591:130-136.
    >> Share

    January 2022
  44. LUPALA CS, Ye Y, Chen H, Su XD, et al
    Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
    Biochem Biophys Res Commun. 2022;590:34-41.
    >> Share

  45. HOSHINO F, Sakane F
    Docosahexaenoic acid-containing phosphatidic acid interacts with clathrin coat assembly protein AP180 and regulates its interaction with clathrin.
    Biochem Biophys Res Commun. 2022;587:69-77.
    >> Share

  46. MAKIYAMA K, Hazawa M, Kobayashi A, Lim K, et al
    NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells.
    Biochem Biophys Res Commun. 2022;586:137-142.
    >> Share

  47. OSTROV DA, Knox GW
    Emerging mutation patterns in SARS-CoV-2 variants.
    Biochem Biophys Res Commun. 2022;586:87-92.
    >> Share

    November 2021
  48. VICTOR J, Deutsch J, Whitaker A, Lamkin EN, et al
    SARS-CoV-2 triggers DNA damage response in Vero E6 cells.
    Biochem Biophys Res Commun. 2021;579:141-145.
    >> Share

  49. ZHENG L, Ma Y, Chen M, Wu G, et al
    SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells.
    Biochem Biophys Res Commun. 2021;579:69-75.
    >> Share

  50. RYU DK, Kang B, Noh H, Woo SJ, et al
    The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;578:91-96.
    >> Share

  51. SASAKI M, Kishimoto M, Itakura Y, Tabata K, et al
    Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells.
    Biochem Biophys Res Commun. 2021;577:146-151.
    >> Share

    October 2021
  52. BARAL P, Bhattarai N, Hossen ML, Stebliankin V, et al
    Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.
    Biochem Biophys Res Commun. 2021;574:14-19.
    >> Share

    September 2021
  53. LONG Y, Song S, Luo F, Han X, et al
    A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.
    Biochem Biophys Res Commun. 2021;571:152-158.
    >> Share

  54. BEGUM F, Srivastava AK, Ray U
    Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
    Biochem Biophys Res Commun. 2021;571:26-31.
    >> Share

  55. OBA M, Rongduo W, Saito A, Okabayashi T, et al
    Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro.
    Biochem Biophys Res Commun. 2021;570:21-25.
    >> Share

    August 2021
  56. RYU DK, Song R, Kim M, Kim YI, et al
    Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.
    Biochem Biophys Res Commun. 2021;566:135-140.
    >> Share

  57. JIN D, Wei J, Sun J
    Analysis of the molecular mechanism of SARS-CoV-2 antibodies.
    Biochem Biophys Res Commun. 2021;566:45-52.
    >> Share

  58. HUANG RY, Herr DR
    Quantitative circular flow immunoassays with trained object recognition to detect antibodies to SARS-CoV-2 membrane glycoprotein.
    Biochem Biophys Res Commun. 2021;565:8-13.
    >> Share

    July 2021
  59. OHKI S, Imamura T, Higashimura Y, Matsumoto K, et al
    Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant.
    Biochem Biophys Res Commun. 2021;563:92-97.
    >> Share

    June 2021
  60. HATAKEYAMA D, Masuda T, Miki R, Ohtsuki S, et al
    In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.
    Biochem Biophys Res Commun. 2021;557:273-279.
    >> Share

  61. ZHAO L, Hao Y, Song Z, Fan Y, et al
    TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination.
    Biochem Biophys Res Commun. 2021;556:87-92.
    >> Share

    May 2021
  62. PADHI AK, Tripathi T
    Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.
    Biochem Biophys Res Commun. 2021;555:147-153.
    >> Share

  63. VANDYCK K, Abdelnabi R, Gupta K, Jochmans D, et al
    ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model.
    Biochem Biophys Res Commun. 2021;555:134-139.
    >> Share

  64. CAO B, Kang T
    Nonlinear adaptive control of COVID-19 with media campaigns and treatment.
    Biochem Biophys Res Commun. 2021;555:202-209.
    >> Share

  65. IDREES D, Kumar V
    SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.
    Biochem Biophys Res Commun. 2021;554:94-98.
    >> Share

  66. KRUSE RL, Huang Y, Smetana H, Gehrie EA, et al
    A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;553:165-171.
    >> Share

  67. ZHANG Y, Niu G, Flisikowska T, Schnieke A, et al
    A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs.
    Biochem Biophys Res Commun. 2021;553:25-29.
    >> Share

    April 2021
  68. PEREIRA F
    SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.
    Biochem Biophys Res Commun. 2021;550:8-14.
    >> Share

    March 2021
  69. SHIBUYA M, Tamiya S, Kawai A, Yoshioka Y, et al
    Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections.
    Biochem Biophys Res Commun. 2021;554:166-172.
    >> Share

  70. SAKURAI Y, Ngwe Tun MM, Kurosaki Y, Sakura T, et al
    5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.
    Biochem Biophys Res Commun. 2021;545:203-207.
    >> Share

  71. ADAMI EA, Chavez Rico SL, Akamatsu MA, Miyaki C, et al
    H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine.
    Biochem Biophys Res Commun. 2021;545:145-149.
    >> Share

  72. SMITS VAJ, Hernandez-Carralero E, Paz-Cabrera MC, Cabrera E, et al
    The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
    Biochem Biophys Res Commun. 2021;543:45-49.
    >> Share

    January 2021
  73. INTAWONG K, Olson D, Chariyalertsak S
    Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
    Biochem Biophys Res Commun. 2021;538:231-237.
    >> Share

  74. SANTORO MG, Carafoli E
    Remdesivir: From Ebola to COVID-19.
    Biochem Biophys Res Commun. 2021;538:145-150.
    >> Share

  75. MOORE KM, Suthar MS
    Comprehensive analysis of COVID-19 during pregnancy.
    Biochem Biophys Res Commun. 2021;538:180-186.
    >> Share

  76. VIANELLO C, Strozzi F, Mocellin P, Cimetta E, et al
    A perspective on early detection systems models for COVID-19 spreading.
    Biochem Biophys Res Commun. 2021;538:244-252.
    >> Share

  77. PASETTO D, Lemaitre JC, Bertuzzo E, Gatto M, et al
    Range of reproduction number estimates for COVID-19 spread.
    Biochem Biophys Res Commun. 2021;538:253-258.
    >> Share

  78. JANS DA, Wagstaff KM
    The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
    Biochem Biophys Res Commun. 2021;538:163-172.
    >> Share

  79. REZNIKOV LR, Norris MH, Vashisht R, Bluhm AP, et al
    Identification of antiviral antihistamines for COVID-19 repurposing.
    Biochem Biophys Res Commun. 2021;538:173-179.
    >> Share

  80. SANTOPOLO S, Riccio A, Santoro MG
    The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
    Biochem Biophys Res Commun. 2021;538:80-87.
    >> Share

  81. BACCA E, Digaetano M, Meschiari M, Franceschini E, et al
    Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature.
    Biochem Biophys Res Commun. 2021;538:151-155.
    >> Share

  82. WATASHI K
    Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
    Biochem Biophys Res Commun. 2021;538:137-144.
    >> Share

  83. WALSH MA, Grimes JM, Stuart DI
    Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics.
    Biochem Biophys Res Commun. 2021;538:40-46.
    >> Share

  84. MOURIER T, Sadykov M, Carr MJ, Gonzalez G, et al
    Host-directed editing of the SARS-CoV-2 genome.
    Biochem Biophys Res Commun. 2021;538:35-39.
    >> Share

  85. CHENG HY, Huang AS
    Proactive and blended approach for COVID-19 control in Taiwan.
    Biochem Biophys Res Commun. 2021;538:238-243.
    >> Share

  86. KALFAOGLU B, Almeida-Santos J, Tye CA, Satou Y, et al
    T-cell dysregulation in COVID-19.
    Biochem Biophys Res Commun. 2021;538:204-210.
    >> Share

  87. JACKSON CB, Zhang L, Farzan M, Choe H, et al
    Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
    Biochem Biophys Res Commun. 2021;538:108-115.
    >> Share

  88. KENNY G, Mallon PW
    COVID19- clinical presentation and therapeutic considerations.
    Biochem Biophys Res Commun. 2021;538:125-131.
    >> Share

  89. SCHENKELBERG T
    Vaccine-induced protection in aging adults and pandemic response.
    Biochem Biophys Res Commun. 2021;538:218-220.
    >> Share

  90. PLATTO S, Wang Y, Zhou J, Carafoli E, et al
    History of the COVID-19 pandemic: Origin, explosion, worldwide spreading.
    Biochem Biophys Res Commun. 2021;538:14-23.
    >> Share

  91. GROVES DC, Rowland-Jones SL, Angyal A
    The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
    Biochem Biophys Res Commun. 2021;538:104-107.
    >> Share

  92. GIOVANETTI M, Benedetti F, Campisi G, Ciccozzi A, et al
    Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.
    Biochem Biophys Res Commun. 2021;538:88-91.
    >> Share

  93. DIPIAZZA AT, Graham BS, Ruckwardt TJ
    T cell immunity to SARS-CoV-2 following natural infection and vaccination.
    Biochem Biophys Res Commun. 2021;538:211-217.
    >> Share

  94. CARRILLO J, Izquierdo-Useros N, Avila-Nieto C, Pradenas E, et al
    Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
    Biochem Biophys Res Commun. 2021;538:187-191.
    >> Share

  95. SARVER DC, Wong GW
    Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19.
    Biochem Biophys Res Commun. 2021;538:92-96.
    >> Share

  96. BAXTER C, Abdool Karim Q, Abdool Karim SS
    Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives.
    Biochem Biophys Res Commun. 2021;538:221-225.
    >> Share

  97. LAI CKC, Lam W
    Laboratory testing for the diagnosis of COVID-19.
    Biochem Biophys Res Commun. 2021;538:226-230.
    >> Share

  98. FANTINI J, Chahinian H, Yahi N
    Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
    Biochem Biophys Res Commun. 2021;538:132-136.
    >> Share

  99. PLATTO S, Zhou J, Wang Y, Wang H, et al
    Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease.
    Biochem Biophys Res Commun. 2021;538:2-13.
    >> Share

  100. ZINZULA L, Basquin J, Bohn S, Beck F, et al
    High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
    Biochem Biophys Res Commun. 2021;538:54-62.
    >> Share

  101. CARAFOLI E
    Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection.
    Biochem Biophys Res Commun. 2021;538:156-162.
    >> Share

  102. JIANG Y, Yin W, Xu HE
    RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.
    Biochem Biophys Res Commun. 2021;538:47-53.
    >> Share


  103. Editorial.
    Biochem Biophys Res Commun. 2021;538:1.
    >> Share

  104. CHAKRABORTY S
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;538:97-103.
    >> Share

  105. GU L, Zhou Y, Wang G, Deng H, et al
    Spatial learning and memory impaired after infection of non-neurotropic influenza virus in BALB/c male mice.
    Biochem Biophys Res Commun. 2021;540:29-36.
    >> Share

  106. SHARMA A, Preece B, Swann H, Fan X, et al
    Structural stability of SARS-CoV-2 virus like particles degrades with temperature.
    Biochem Biophys Res Commun. 2021;534:343-346.
    >> Share

  107. INTAWONG K, Olson D, Chariyalertsak S
    Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
    Biochem Biophys Res Commun. 2021;534:830-836.
    >> Share

  108. LIMA MA, Skidmore M, Khanim F, Richardson A, et al
    Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2.
    Biochem Biophys Res Commun. 2021;534:485-490.
    >> Share

  109. CHAKRABORTY S
    Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
    Biochem Biophys Res Commun. 2021;534:374-380.
    >> Share

    November 2020
  110. JEREMIAH SS, Miyakawa K, Morita T, Yamaoka Y, et al
    Potent antiviral effect of silver nanoparticles on SARS-CoV-2.
    Biochem Biophys Res Commun. 2020;533:195-200.
    >> Share

    October 2020
  111. TUNG HYL, Limtung P
    Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.
    Biochem Biophys Res Commun. 2020;532:134-138.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016